Temat: "Quinolines" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: [Application of neratinib in the treatment of hormone receptor and HER-2 double positive breast cancer].
Autorzy:: Wang X; Department of VIP Medical Services, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Yuan P; Department of VIP Medical Services, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.; Pokaż więcej
Źródło:: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2021 May 23; Vol. 43 (5), pp. 511-515.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/drug therapy
Quinolines*/therapeutic use
Hormones ; Humans ; Phosphatidylinositol 3-Kinases ; Receptor, ErbB-2

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: [Treatment of ALK negative metastatic inflammatory myofibroblastic tumor by combination of pembrolizumab and anlotinib: a case report].
Autorzy:: Li XS; Department of Oncology and Hematology, the Second Hospital of Jilin University, Changchun 130041, China.
Li XF; Department of Oncology and Hematology, the Second Hospital of Jilin University, Changchun 130041, China.
Jin LF; Department of Oncology and Hematology, the Second Hospital of Jilin University, Changchun 130041, China.
Zhao Y; Department of Oncology and Hematology, the Second Hospital of Jilin University, Changchun 130041, China.
Shen WZ; Department of Oncology and Hematology, the Second Hospital of Jilin University, Changchun 130041, China.; Pokaż więcej
Źródło:: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2021 Feb 23; Vol. 43 (2), pp. 240-242.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Neoplasms*
Quinolines*
Antibodies, Monoclonal, Humanized ; Biomarkers, Tumor ; Humans ; Indoles ; Receptor Protein-Tyrosine Kinases

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: [Long term follow-up results of anlotinib in the treatment of advanced renal cell carcinoma].
Autorzy:: Song Y; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Yihebali C; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Yang L; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Cui CX; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Zhang W; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Sun YK; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Du CX; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Zhou AP; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Wang JW; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.; Pokaż więcej
Źródło:: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2020 Sep 23; Vol. 42 (9), pp. 765-770.
Typ publikacji:: Journal Article
MeSH Terms:: Antineoplastic Agents*/therapeutic use
Carcinoma, Renal Cell*/drug therapy
Kidney Neoplasms*/drug therapy
Disease-Free Survival ; Follow-Up Studies ; Humans ; Indoles/therapeutic use ; Quinolines/therapeutic use ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: [A case report of anlotinib treatment of an advanced lung squamous cell cancer patients without driver gene mutations].
Autorzy:: Liu YH; Department of Medical Oncology, Xuzhou Central Hospital, Xuzhou 221009, China.
Zhang YW
Li JS
Dai XM; Pokaż więcej
Źródło:: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2019 Jun 23; Vol. 41 (6), pp. 447-448.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Antineoplastic Agents/*therapeutic use
Carcinoma, Non-Small-Cell Lung/*drug therapy
Indoles/*therapeutic use
Lung Neoplasms/*drug therapy
Quinolines/*therapeutic use
Carcinoma, Non-Small-Cell Lung/pathology ; Epithelial Cells ; Humans ; Lung Neoplasms/pathology ; Mutation ; Severity of Illness Index ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: [Molecular mechanisms of resistance to phosphatidyl inositol 3-kinase inhibitors in triple-negative breast cancer cells].
Autorzy:: Zhang WL; Department of General Surgery, the Rockets Army General hospital of PLA, Beijing 100088, China.
Ma WJ; Health Team, Public Security Frontier Detachment of Dandong, Dandong 118000, China.
Chen S; Department of General Surgery, the Rockets Army General hospital of PLA, Beijing 100088, China.
Wu XZ; Department of Pathology, the Rockets Army General hospital of PLA, Beijing 100088, China.
Zhang HR; Department of General Surgery, the Rockets Army General hospital of PLA, Beijing 100088, China.
Zhang JH; Department of General Surgery, the Rockets Army General hospital of PLA, Beijing 100088, China.; Pokaż więcej
Źródło:: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2016 Aug; Vol. 38 (8), pp. 578-88.
Typ publikacji:: Journal Article
MeSH Terms:: Drug Resistance, Neoplasm*
Triple Negative Breast Neoplasms*
Adaptor Proteins, Signal Transducing ; Aminopyridines ; Animals ; Cell Cycle Proteins ; Cell Line, Tumor ; Cell Proliferation ; Humans ; Imidazoles ; Mice ; Morpholines ; Phosphatidylinositol 3-Kinase ; Phosphatidylinositol 3-Kinases ; Phosphoproteins ; Proto-Oncogene Proteins c-akt ; Quinolines ; Signal Transduction ; TOR Serine-Threonine Kinases ; beta Catenin

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Quinolines"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat